Anela previously worked at Apollo Health Ventures from 2020 to 2025 as a Principal based in Berlin. She works across funds, covering both venture creation opportunities and external dealflow. She currently serves as a Director on Boards of Samsara Therapeutics and Refoxy Pharmaceuticals, respectively. Before joining Apollo Health Ventures, she worked at a boutique consulting firm Catenion, where she has managed international projects for Big Pharma and biotech upstarts regarding R&D strategy and advised top tier VCs and hedge funds on their investment decisions. Anela holds a PhD in neurobiology from the Free University of Berlin and her work was published in top ranked peer reviewed journals.